Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
rEVO Biologics
rEVO Biologics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Atryn
Antithrombin alfa
2009-02-06
Antithrombin iii deficiency
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Antithrombin alfa
congenital heart defects
,
postoperative hemorrhage
,
healthy volunteers/patients
,
renal dialysis
,
covid-19
,
sepsis
,
liver cirrhosis
,
syndrome
,
liver failure
,
hepatic insufficiency
,
venous thromboembolism
,
thromboembolism
,
reperfusion injury
,
coronary artery bypass
,
respiratory distress syndrome
,
severe acute respiratory syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
cardiac surgical procedures
,
hepatic veno-occlusive disease
,
end stage liver disease
,
fibrosis
,
acute-on-chronic liver failure
,
wounds and injuries
,
blood coagulation disorders
,
hemostatic disorders
,
venous thrombosis
,
cardiopulmonary bypass
,
disseminated intravascular coagulation
,
extracorporeal membrane oxygenation
,
menopause
,
antithrombin iii deficiency
,
thrombosis
,
hemophilia a
,
thrombophilia
,
pre-eclampsia
,
myocardial infarction
,
infarction
,
acute coronary syndrome
,
aortic valve stenosis
,
aortic valve insufficiency
,
mitral valve insufficiency
,
mitral valve stenosis
,
toxemia
,
coagulation protein disorders
,
hemorrhage
,
congenital disorders of glycosylation
,
atrial fibrillation
,
embolic stroke
,
recurrence
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
sickle cell anemia
,
hemolysis
,
hemolytic anemia
,
heart failure
,
thrombocytopenia
,
environmental biomarkers
,
postmenopause
,
cicatrix
,
burns
,
factor xiii deficiency
,
migraine disorders
,
acute-phase reaction
,
antiphospholipid syndrome
,
malnutrition
,
fatal outcome
,
cytokine release syndrome
,
septic shock
,
upper extremity deep vein thrombosis
,
nephritis
,
transfusion reaction
,
liver transplantation
,
heart diseases
,
heart septal defects
,
pancreatitis
,
acute kidney injury
,
portal hypertension
,
embolism
,
budd-chiari syndrome
,
chronic renal insufficiency
,
post-acute covid-19 syndrome
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
Benzocaine
seizures
Serine
geographic atrophy
,
atrophy
Bevifimod
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
interdigitating dendritic cell sarcoma
,
b-cell chronic lymphocytic leukemia
,
leukemia
,
lymphoma
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
b-cell lymphoma
,
non-small-cell lung carcinoma
,
hematologic diseases
Nadide
healthy volunteers/patients
,
infections
,
acquired immunodeficiency syndrome
,
hepatitis c
,
non-small-cell lung carcinoma
,
neoplasms
,
bacterial infections
,
toxoplasmosis
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
ulcer
,
buruli ulcer
,
hiv infections
,
streptococcal infections
,
pneumococcal infections
,
fever
,
meningococcal infections
,
pneumococcal pneumonia
,
premature birth
,
sexually transmitted diseases
,
herpes simplex
,
prostatic hyperplasia
,
hyperplasia
Crystalloid
healthy volunteers/patients
,
osteoarthritis
,
major depressive disorder
,
prostatic hyperplasia
,
skin aging
,
carpal tunnel syndrome
,
premature ejaculation
,
neuralgia
,
hyperalgesia
,
cicatrix
,
torticollis
,
depression
,
systemic lupus erythematosus
,
muscle spasticity
,
stroke
,
urinary incontinence
,
cerebral palsy
,
migraine disorders
,
multiple sclerosis
,
neurogenic urinary bladder
,
overactive urinary bladder
Rfviia
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use